BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Aryl hydrocarbon receptor nuclear translocator-like 2 (ARNTL2; BMAL2)

April 21, 2016 7:00 AM UTC

Patient sample, cell culture and mouse studies suggest inhibiting ARNTL2 could help treat metastatic lung adenocarcinoma. In patient samples, ARNTL2 levels were higher in metastatic tumors and primary...